These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 21701774

  • 1. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY, Park YS, Nam JH.
    Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
    [Abstract] [Full Text] [Related]

  • 2. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST.
    Clin Cancer Res; 2004 Nov 15; 10(22):7629-36. PubMed ID: 15569995
    [Abstract] [Full Text] [Related]

  • 3. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.
    Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, Fan ST.
    Hepatology; 2008 May 15; 47(5):1524-32. PubMed ID: 18393387
    [Abstract] [Full Text] [Related]

  • 4. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL.
    Ai Zheng; 2004 Jun 15; 23(6):619-25. PubMed ID: 15191658
    [Abstract] [Full Text] [Related]

  • 5. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY, Chen LB, Xu JY, Yang Z, Xu RH, Wei HY.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):481-4. PubMed ID: 16772086
    [Abstract] [Full Text] [Related]

  • 6. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL, Huang WD, Qian QJ, Zhao FL, Liu XY.
    Hum Gene Ther; 2011 Sep 01; 22(9):1109-19. PubMed ID: 21361790
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, Zhang JP.
    Chin Med J (Engl); 2011 Nov 01; 124(22):3794-9. PubMed ID: 22340243
    [Abstract] [Full Text] [Related]

  • 8. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].
    Xu WJ, Zhang S, Zhang N, Yang Y, Wei YQ, Deng HX.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul 01; 42(4):455-60. PubMed ID: 21866625
    [Abstract] [Full Text] [Related]

  • 9. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A.
    Cancer Gene Ther; 2010 Apr 01; 17(4):275-88. PubMed ID: 19876077
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J, Liu F, Chen X, Zhao P, Su N, Xie G, Chen J, Zheng D, Luo R.
    Int J Mol Med; 2011 Oct 01; 28(4):497-503. PubMed ID: 21617840
    [Abstract] [Full Text] [Related]

  • 11. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
    Deng Q, Wang Q, Zong WY, Zheng DL, Wen YX, Wang KS, Teng XM, Zhang X, Huang J, Han ZG.
    Cancer Res; 2010 Jan 15; 70(2):782-91. PubMed ID: 20068156
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Yang H, Xiong F, Wei X, Yang Y, McNutt MA, Zhou R.
    Cancer Lett; 2010 Aug 28; 294(2):236-44. PubMed ID: 20202745
    [Abstract] [Full Text] [Related]

  • 13. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.
    Transl Res; 2007 Nov 28; 150(5):281-94. PubMed ID: 17964517
    [Abstract] [Full Text] [Related]

  • 14. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST.
    Oncotarget; 2016 Apr 19; 7(16):21644-57. PubMed ID: 26942873
    [Abstract] [Full Text] [Related]

  • 15. Effects of silencing cyclooxygenase-2 expression via RNA interference on the tumorigenicity of the SMMC-7721 human hepatocarcinoma cell line.
    Liu LL, Lin LR, Tong ML, Fu ZG, Liu GL, Zheng WH, Liu F, Zhang DW, Zhang ZY, Yang TC.
    Oncol Rep; 2012 Jun 19; 27(6):1829-34. PubMed ID: 22378232
    [Abstract] [Full Text] [Related]

  • 16. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep 19; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 17. GEP associates with wild-type p53 in hepatocellular carcinoma.
    Cheung ST, Wong SY, Lee YT, Fan ST.
    Oncol Rep; 2006 Jun 19; 15(6):1507-11. PubMed ID: 16685387
    [Abstract] [Full Text] [Related]

  • 18. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y, Poon RT, Li Q, Kok TW, Lau C, Fan ST.
    Cancer Res; 2005 May 01; 65(9):3691-9. PubMed ID: 15867364
    [Abstract] [Full Text] [Related]

  • 19. Potent antitumor activity in experimental hepatocellular carcinoma by adenovirus-mediated coexpression of TRAIL and shRNA against COX-2.
    Chen Q, Lou W, Shen J, Ma L, Yang Z, Liu L, Luo J, Qian C.
    Clin Cancer Res; 2010 Jul 15; 16(14):3696-705. PubMed ID: 20515870
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.
    Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.